Skip to main content
. 2013 Sep 16;11(1):49–57. doi: 10.1038/cmi.2013.40

Figure 3.

Figure 3

Recombinant DHX33 can rescue the defect in poly I:C-activated IFN production caused by DHX33 shRNA knockdown. (a) Immunoblot of endogenous DHX33 in D2SC mDCs (Control) and recombinant HA-DHX33 (sh+HA-X33) in D2SC mDCs in which endogenous DHX33 was selectively knocked down (shDHX33). (b) ELISA of IFN-β production by D2SC mDCs. IFN, interferon; mDC, myeloid dendritic cell; shRNA, small heteroduplex RNA.